Noida, UP -- (SBWIRE) -- 12/22/2014 -- One of the major breakthroughs that genetic testing has paved way for includes "Personalized Medicine". Personalized medicine is the use of new methods of molecular analysis for better management of a patient's disease or predisposition towards a disease. PGx, the study of variations of DNA and RNA characteristics as related to drug response, is one of the most exciting areas of personalized medicine today. Patients typically have variability in response to many drugs that are currently available. PGx seeks to understand how differences in genes and their expression affect the body's response to medications. Such approaches promise the advent of "Personalized Medicine" in which drugs and drug combinations are optimized for each individual's unique genetic makeup.

Advances in PGx have opened new possibilities in drug discovery and development. PGx has allowed for more tailored treatment of a wide range of health problems, including cardiovascular disease, cancer, and HIV/AIDS. Personalized medicines aim to achieve optimal medical outcomes by helping physicians and patients choose the disease management approaches that are likely to work best in the context of the patient's unique genetic and environmental profile. Such approaches may include genetic screening programs that more precisely diagnose diseases and their sub-types, or help physicians select the type and dose of medication best suited to a certain group of patients.

Holistically, the research report "Genetic Testing Market Outlook 2018", thoroughly discusses the global genetic testing industry in terms of the overall market size. Moreover, the disease wise and region wise analysis is also discussed in detail. Apart from the statistical data analysis highlighted above, qualitative data including the emerging sector for genetic testing industry and the government regulations are also elicited exhaustively. The competition across the global genetic testing sector is intensifying with the days passing by. With new service providers entering the market and accelerated R&D activities, the application of genetic testing and the industry as a whole is bound to witness a swift growth in the years to come.

For FREE SAMPLE of this report visit:
http://www.rncos.com/Report/IM720.htm

Check Related REPORTS on:
http://www.rncos.com/Healthcare_Industry.htm

About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.